文献速递临床试验与 GCP

简短叙事暴露疗法联合个案管理对重症监护后创伤后应激障碍患者初级诊疗效果的随机对照试验方案

Effect of a combined brief narrative exposure therapy with case management versus treatment as usual in primary care for patients with traumatic stress sequelae following intensive care medicine: study protocol for a multicenter randomized controlled trial (PICTURE).
PubMed 文献 · Trials · 2018-09-10

PICTURE试验是一项在德国开展的、由研究者发起的多中心、初级保健机构为基础的随机对照优效性试验方案。计划纳入340例重症监护治疗后3个月创伤后诊断量表第五版(PDS-5)总分至少20分的成人患者,随机分为接受简短叙事暴露疗法(NET)联合个案管理与改进常规治疗(iTAU)两组。主要复合终点为第6个月时PDS-5总分较基线的绝对变化,以评估该联合干预对创伤后应激障碍症状的疗效。

要点

  • 重症监护幸存者PTSD风险高,初级保健是其主要诊疗场所。
  • 试验比较简短NET联合个案管理与iTAU对PTSD症状的改善效果。
  • 主要终点为第6个月PDS-5总分较基线的绝对变化。

核心结论

  • 若试验证实实验性干预优于常规治疗,简短NET联合个案管理或可成为缓解PTSD相关症状并改善重症监护后初级保健的治疗选择。

研究设计与样本

  • 研究为研究者发起的多中心、初级保健为基础、随机对照两臂平行组、观察者盲法的优效性试验,在德国开展。
  • 计划纳入340例成人患者,重症监护治疗后3个月PDS-5总分至少20分,等量随机分为NET联合个案管理组与iTAU组。

主要发现

  • 原文未报告试验结果,仅描述研究方案。

关键数值与推荐

  • 纳入标准:重症监护治疗后3个月PDS-5总分至少20分的成人患者。
  • 主要复合终点为第6个月时PDS-5总分较基线的绝对变化,并纳入研究期间任何患者死亡。
  • 干预组:初级保健医生接受培训后提供简短NET(3次)并辅以医疗助理的电话个案管理;对照组:初级保健医生在3次咨询中提供常规治疗。

临床怎么用

  • 初级保健医生可根据现行德国指南诊断和治疗PTSD;若试验优效,可考虑采用简短NET联合个案管理。

局限性

  • 原文为首要研究方案,尚未报告干预效果数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Traumatic events like critical illness and intensive care are threats to life and bodily integrity and pose a risk factor for posttraumatic stress disorder (PTSD). PTSD affects the quality of life and morbidity and may increase health-care costs. Limited access to specialist care results in PTSD patients being treated in primary care settings. Narrative exposure therapy (NET) is based on the principles of cognitive behavioral therapy and has shown positive effects when delivered by health-care professionals other than psychologists. The primary aims of the PICTURE trial (from "PTSD after ICU survival") are to investigate the effectiveness and applicability of NET adapted for primary care with case management in adults diagnosed with PTSD after intensive care. METHODS/DESIGN: This is an investigator-initiated, multi-center, primary care-based, randomized controlled two-arm parallel group, observer-blinded superiority trial conducted throughout Germany. In total, 340 adult patients with a total score of at least 20 points on the posttraumatic diagnostic scale (PDS-5) 3 months after receiving intensive care treatment will be equally randomized to two groups: NET combined with case management and improved treatment as usual (iTAU). All primary care physicians (PCPs) involved will be instructed in the diagnosis and treatment of PTSD according to current German guidelines. PCPs in the iTAU group will deliver usual care during three consultations. In the experimental group, PCPs will additionally be trained to deliver an adapted version of NET (three sessions) supported by phone-based case management by a medical assistant. At 6 and 12 months after randomization, structured blinded telephone interviews will assess patient-reported outcomes. The primary composite endpoint is the absolute change from baseline at month 6 in PTSD symptom severity measured by the PDS-5 total score, which also incorporates the death of any study patients. Secondary outcomes cover the domains depression, anxiety, disability, health-related quality-of-life, and cost-effectiveness. The principal analysis is by intention to treat. DISCUSSION: If the superiority of the experimental intervention over usual care can be demonstrated, the combination of brief NET and case management could be a treatment option to relieve PTSD-related symptoms and to improve primary care after intensive care. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03315390 . Registered on 10 October 2017. German Clinical Trials Register, DRKS00012589 . Registered on 17 October 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Gensichen J, Schultz S, Adrion C, et al. Effect of a combined brief narrative exposure therapy with case management versus treatment as usual in primary care for patients with traumatic stress sequelae following intensive care medicine: study protocol for a multicenter randomized controlled trial (PICTURE). Trials. 2018. PMID: 30201053. doi:10.1186/s13063-018-2853-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。